References
- Annegers JF, Coan SP. The risks of epilepsy after traumatic brain injury. Seizure 2000;9:453–7. [Internet].
- Frey LC. Epidemiology of posttraumatic epilepsy: a critical review. Epilepsia 2003;44(Suppl 1):11–7.
- Agrawal A, Timothy J, Pandit L, et al. Post-traumatic epilepsy: an overview. Clin Neurol Neurosurg [Internet]. 2006;108:433–9. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0303846705001514
- Claassen J, Mayer SA, Kowalski RG, et al. Detection of electrographic seizures with continuous EEG monitoring in critically ill patients. Neurology 2004;62:1743–8.
- Asikainen I, Kaste M, Sarna S. Early and late posttraumatic seizures in traumatic brain injury rehabilitation patients: brain injury factors causing late seizures and influence of seizures on long-term outcome. Epilepsia 1999;40:584–9.
- Andelic N, Hammergren N, Bautz-Holter E, et al. Functional outcome and health-related quality of life 10 years after moderate-to-severe traumatic brain injury. Acta Neurol Scand 2009;120:16–23. [Internet]. Blackwell Publishing Ltd; Available from: http://doi.wiley.com/10.1111/j.1600-0404.2008.01116.x
- Klein P, Tyrlikova I. Epilepsy & Behavior Prevention of epilepsy: Should we be avoiding clinical trials? Epilepsy Behav [Internet]. Elsevier Inc.; 2017;72:188–94. Available from: http://dx.doi.org/10.1016/j.yebeh.2017.05.024
- Annegers JF, Hauser WA, Coan SP, et al. A population-based study of seizures after traumatic brain injuries. N Engl J Med [Internet]. Massachusetts Medical Society; 1998; [cited 2016 Aug 21]338:20–4. Available from: http://www.nejm.org/doi/abs/10.1056/NEJM199801013380104
- Beghi E. Overview of studies to prevent posttraumatic epilepsy. Epilepsia 2003;44:21–6.
- Carney N, Totten AM, Reilly CO, et al. Guidelines for the management of severe traumatic brain injury 4th Edition. Neurosurgery 2017;80:6–15.
- Temkin NR, Dikmen SS, Wilensky AJ, et al. A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures. N Engl J Med 1990;323:497–502.
- Temkin NR, Dikmen SS, Anderson GD, et al. Valproate therapy for prevention of posttraumatic seizures: a randomized trial. J Neurosurg 1999;91:593–600.
- Manaka S. Cooperative prospective study on posttraumatic epilepsy: risk factors and the effect of prophylactic anticonvulsant. Jpn J Psychiatry Neurol 1992;46:311–5. [Internet]. Available from: http://doi.wiley.com/10.1111/j.1440-1819.1992.tb00865.x
- Young B, Rapp RP, Norton JA, et al. Failure of prophylactically administered phenytoin to prevent post- traumatic seizures in children. Childs Brain 1983;10:185–92.
- Thompson K, Pohlmann EB, Campbell LA, et al. Pharmacological treatments for preventing epilepsy following traumatic head injury. Cochrane Database Syst 2012;1–15.
- Dikmen SS, Temkin NR, Miller B, et al. Neurobehavioral effects of phenytoin prophylaxis of posttraumatic seizures. JAMA 1991;265:1271–7. [Internet]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1995974
- Bhullar IS, Johnson D, Paul JP, Kerwin AJ, Tepas JJ, Frykberg ER. More harm than good: antiseizure prophylaxis after traumatic brain injury does not decrease seizure rates but may inhibit functional recovery. J Trauma Acute Care Surg 2014;76:54–60. [Internet]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24368357
- Jones GL, Wimbish GH, McIntosh WE. Phenytoin: basic and clinical pharmacology. Med Res Rev 1983;3:383–434. [Internet]. Jan [cited 2015 Oct 25]Available from: http://www.ncbi.nlm.nih.gov/pubmed/6358722
- Sahin S, Comert A, Akin O, et al. Cutaneous drug eruptions by current antiepileptics: case reports and alternative treatment options. Clin Neuropharmacol 2008;31:93–6. [Internet]. Jan [cited 2015 Oct 25] Available from: http://www.ncbi.nlm.nih.gov/pubmed/18382181
- Cuttle L, Munns AJ, Hogg NA, et al. Metabolism by Human Cytochrome P450: involvement of P450 3A and 2C Forms in Secondary Metabolism and Drug-Protein Adduct Formation. Drug Metab Dispos. 2000;28:945–950. [Internet]. Aug [Cited 2016 Aug 25] Available from. Phenytoin http://www.ncbi.nlm.nih.gov/pubmed/10901705
- Shohrati M, Rouini MR, Mojtahedzadeh M, et al. Evaluation of phenytoin pharmacokinetics in neurotrauma patients. DARU 2007;15:34–40.
- Kruer RM, Harris LH, Goodwin H, et al. Changing trends in the use of seizure prophylaxis after traumatic brain injury: A shift from phenytoin to levetiracetam. J Crit Care 2013;28:883.e9–.e13. Elsevier Inc.; Available from: http://dx.doi.org/10.1016/j.jcrc.2012.11.020
- Wu T, Chen CC, Chen TC, et al. Clinical efficacy and cognitive and neuropsychological effects of levetiracetam. Epilepsy Behav 2009;16:468–74.
- Fuller KL, Wang YY, Cook MJ, et al. Tolerability, safety, and side effects of levetiracetam versus phenytoin in intravenous and total prophylactic regimen among craniotomy patients: a prospective randomized study. Epilepsia 2013;54:45–57. United States; Jan.
- Klein P, Herr D, Pearl PL, et al. Results of phase II pharmacokinetic study of levetiracetam. Epilepsy Behav 2012;24:457–61.
- Klein P, Herr D, Pearl PL, et al. Results of phase 2 safety and feasibility study of treatment with levetiracetam for prevention of posttraumatic epilepsy. Arch Neurol 2012;69:1290–5. United States; Oct.
- Swaroop HS, Ananya C, Nithin K, et al. Levetiracetam: a review of its use in the treatment of epilepsy. 2013;2:166–72.
- Zafar SN, Khan AA, Ghauri AA, et al. Phenytoin versus Leviteracetam for seizure prophylaxis after brain injury - a meta analysis. BMC Neurol 2012;12:30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22642837
- Meshkini A, Ghojazadeh M, Golbahar-Haghighi A, et al. Comparison of levetiracetam versus phenytoin for seizure prophylaxis in patients with traumatic brain injury: a meta-analysis. J Anal Res Clin Med 2015;3:118–25. [Internet]. Available from: http://journals.tbzmed.ac.ir/JARCM/Abstract/JARCM_2481_20141129144536
- Higgins JPT, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928–d5928. [Internet]. Available from: http://www.bmj.com/cgi/doi/10.1136/bmj.d5928
- Wells GA, Shea B, O´Connell D, et al. The newcastle-ottawa scale (nos) for assessing the quality of non-randomized studies in meta-analyses. 2009 [cited 2016 Aug 8]; Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
- Cleland J, Durning SJ, Researching Medical Education [Internet]. Wiley; 2015 [cited 2016 Jan 2]. 320 p. Available from: https://books.google.com/books?id=LEb3CQAAQBAJ&pgis=1
- Vespa PM, Nuwer MR, Nenov V, et al. Increased incidence and impact of nonconvulsive and convulsive seizures after traumatic brain injury as detected by continuous electroencephalographic monitoring. J Neurosurg 1999;91:750–60.
- Sutter R, Fuhr P, Grize L, et al. Continuous video-EEG monitoring increases detection rate of nonconvulsive status epilepticus in the ICU. Epilepsia 2011;52:453–7.
- Dudek FE, Staley KJ. The time course of acquired epilepsy: Implications for therapeutic intervention to suppress epileptogenesis. Neurosci Lett 2011;497:240–6. Elsevier; Jun 27 [cited 2018 Mar 13] Available from: https://www.sciencedirect.com/science/article/abs/pii/S0304394011003855
- Echegoyen J, Armstrong C, Morgan RJ, et al. Single application of a CB1 receptor antagonist rapidly following head injury prevents long-term hyperexcitability in a rat model. Epilepsy Res 2009;85:123–7.
- Gabriel WM, Rowe a. S, Gabriel WM, et al. Long-term comparison of GOS-E scores in patients treated with phenytoin or levetiracetam for posttraumatic seizure prophylaxis after traumatic brain injury. Ann Pharmacother 2014;48:1440–4. United States; Nov [cited 2015 Dec 23]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25169249
- Szaflarski JP, Sangha KS, Lindsell CJ, et al. Prospective, randomized, single-blinded comparative trial of intravenous levetiracetam versus phenytoin for seizure prophylaxis. Neurocrit Care 2010;12:165–72. United States; Apr [cited 2015 Dec 23]. Available from: http://link.springer.com/10.1007/s12028-009-9304-y
- Kruer RM, Harris LH, Goodwin H, et al. Changing trends in the use of seizure prophylaxis after traumatic. J Crit Care 2013;28. United States; Oct 883.e9–883.e13.
- Szaflarski JP. Is there equipoise between phenytoin and levetiracetam for seizure prevention in traumatic brain injury? Epilepsy Curr 2015;15:94–7.
- Pieracci FM, Moore EE, Beauchamp K, et al. A cost-minimization analysis of phenytoin versus levetiracetam for early seizure pharmacoprophylaxis after traumatic brain injury. J Trauma Acute Care Surg 2012;72:276–81. United States; Jan.
- Cotton BA, Kao LS, Kozar R, et al. Cost-utility analysis of levetiracetam and phenytoin for posttraumatic seizure prophylaxis. J Trauma 2011;71:375–9. United States; Aug.
- Kazerooni R, Bounthavong M. Cost-effectiveness analysis of intravenous levetiracetam versus intravenous phenytoin for early onset seizure prophylaxis after neurosurgery and traumatic brain injury. Clinicoecon Outcomes Res 2010;2:15–23. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3169955&tool=pmcentrez&render-type=abstract